A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908)
一项 II 期随机试验比较了标准剂量和低剂量利妥昔单抗联合阿仑单抗作为老年患者进展性慢性淋巴细胞白血病初始治疗的疗效:ECOG-ACRIN 癌症研究组的一项试验 (E1908)
期刊:American Journal of Hematology
影响因子:9.9
doi:10.1002/ajh.24265
Zent, Clive S; Victoria Wang, Xin; Ketterling, Rhett P; Hanson, Curtis A; Libby, Edward N; Barrientos, Jacqueline C; Call, Timothy G; Chang, Julie E; Liu, Jane J; Calvo, Alejandro R; Lazarus, Hillard M; Rowe, Jacob M; Luger, Selina M; Litzow, Mark R; Tallman, Martin S